About Ertan Köseoğlu

This author has not yet filled in any details.
So far Ertan Köseoğlu has created 205 blog entries.

Monday August 14th, 2017

(Turkish) QuintilesIMS Birleşik Krallık ve İrlanda operasyonunda Klinik Operasyonlar Direktörü Şebnem YILDIRIMOĞLU

2017-08-18T15:50:41+00:00

Sorry, this entry is only available in Turkish.

(Turkish) QuintilesIMS Birleşik Krallık ve İrlanda operasyonunda Klinik Operasyonlar Direktörü Şebnem YILDIRIMOĞLU 2017-08-18T15:50:41+00:00

(Turkish) 27 Eylül 2017- Onkoloji’de Klinik Çalışmalar Kalite Sempozyumu ve 28-29 Eylül 2017 Onkoloji Kongresi

2017-08-04T17:02:29+00:00

Değerli üyelerimiz, 28-29 Eylül 2017 tarihinde, Antalya Gloria Golf Otel’de Uluslararası Onkoloji Kongresi gerçekleştirilecektir. Kongre öncesinde, 27 Eylül 2017 tarihinde ise, Antalya Gloria Golf Otel’de gerçekleştirilecek olan üyelerimizden de konuşmacı olarak katılacakların yer aldığı (Daha önce sizlere duyurarak konuşmacı önerilerinizi talep etmiştik) “Onkoloji’de Klinik Çalışmalar Kalite Sempozyumu”  yapılacaktır. Bu sempozyuma ilişkin programı ekte göndermekteyiz. Konuşmacılar [...]

(Turkish) 27 Eylül 2017- Onkoloji’de Klinik Çalışmalar Kalite Sempozyumu ve 28-29 Eylül 2017 Onkoloji Kongresi 2017-08-04T17:02:29+00:00

Friday June 2nd, 2017

Green light given for new EudraVigilance system for collection and monitoring of suspected adverse reactions

2017-06-02T09:56:36+00:00

The European Medicines Agency (EMA) will launch a new and improved version of EudraVigilance, the European information system of suspected adverse reactions to medicines that are authorised or being studied in clinical trials in the European Economic Area (EEA). The new version of EudraVigilance will go live on 22 November 2017 with enhanced functionalities for [...]

Green light given for new EudraVigilance system for collection and monitoring of suspected adverse reactions 2017-06-02T09:56:36+00:00

Wednesday May 10th, 2017

FDA approves drug to treat ALS

2017-05-10T08:15:05+00:00

The U.S. Food and Drug Administration today approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease. “After learning about the use of edaravone to treat ALS in Japan, we rapidly engaged with the drug developer about filing a marketing application in the United States,” said Eric [...]

FDA approves drug to treat ALS 2017-05-10T08:15:05+00:00

FDA approves new combination treatment for acute myeloid leukemia

2017-05-10T08:12:37+00:00

The U.S. Food and Drug Administration today approved Rydapt (midostaurin) for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who have a specific genetic mutation called FLT3, in combination with chemotherapy. The drug is approved for use with a companion diagnostic, the LeukoStrat CDx FLT3 Mutation Assay, which is used to [...]

FDA approves new combination treatment for acute myeloid leukemia 2017-05-10T08:12:37+00:00